scholarly journals A Randomised, Double-Blind, Placebo-Controlled Trial of Actovegin in Patients with Post-Stroke Cognitive Impairment: ARTEMIDA Study Design

2013 ◽  
Vol 3 (1) ◽  
pp. 459-467 ◽  
Author(s):  
Alla Guekht ◽  
Ingmar Skoog ◽  
Amos D. Korczyn ◽  
Vladimir Zakharov ◽  
Martin Eeg ◽  
...  
Keyword(s):  
Cognitive Impairment ◽  
Study Design ◽  
Controlled Trial ◽  
Double Blind ◽  
Double Blind Placebo ◽  
Post Stroke

A Randomized, Double-blind, Placebo Controlled-trial of Triflusal in Mild Cognitive Impairment

2008 ◽  
Vol 22 (1) ◽  
pp. 21-29 ◽  
Author(s):  
Teresa Gómez-Isla ◽  
Rafael Blesa ◽  
Merce Boada ◽  
Jordi Clarimón ◽  
Teodoro Del Ser ◽  
...  
Keyword(s):  
Cognitive Impairment ◽  
Mild Cognitive Impairment ◽  
Controlled Trial ◽  
Double Blind ◽  
Double Blind Placebo

scholarly journals Botulinum toxin type A in post-stroke lower limb spasticity: a multicenter, double-blind, placebo-controlled trial

2010 ◽  
Vol 257 (8) ◽  
pp. 1330-1337 ◽  
Author(s):  
Ryuji Kaji ◽  
Yuka Osako ◽  
Kazuaki Suyama ◽  
Toshio Maeda ◽  
Yasuyuki Uechi ◽  
...  
Keyword(s):  
Botulinum Toxin ◽  
Lower Limb ◽  
Controlled Trial ◽  
Botulinum Toxin Type A ◽  
Botulinum Toxin Type ◽  
Double Blind ◽  
Double Blind Placebo ◽  
Post Stroke ◽  
Limb Spasticity ◽  
Lower Limb Spasticity

A randomized, double-blind, placebo-controlled trial of deprenyl and thiotic acid in HIV-associated cognitive impairment

Neurology ◽  
1999 ◽  
Vol 52 (9) ◽  
pp. 1920-1920 ◽  
Author(s):  
A. Di Rocco ◽  
R. Roesler ◽  
J. Quevedo ◽  
R. Walz ◽  
M. Bianchin ◽  
...  
Keyword(s):  
Cognitive Impairment ◽  
Controlled Trial ◽  
Double Blind ◽  
Double Blind Placebo
Sign in / Sign up

Export Citation Format

Share Document